Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Mark Trafford Promoted to Serve Alongside Wright to Lead the Region NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced the appointment of David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest. Meanwhile, Mark Trafford has been promoted to serve alongside Wright to co-lead the region. Both report to Ed Harrington, Executive Vice President and Head of Private Client Division at Oppenheimer. "We are thrilled to welcome David to Oppenheimer," said Harrington. "He brings the right energy, deep market knowledge and leaders
NEW YORK, Aug. 1, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. Robert S. Lowenthal, President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several yea
Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
10-Q - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
NEW YORK, Aug. 1, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. Robert S. Lowenthal, President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several yea
NEW YORK, April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025, compared with net income of $26.1 million or $2.50 basic earnings per share for the first quarter of 2024. Revenue for the first quarter of 2025 was $367.8 million, an increase of 4.2%, compared to revenue of $353.1 million for the first quarter of 2024. Albert G. Lowenthal, Chairman and CEO commented, "The Firm's solid performance for the quarter underscores the ability of our diversified businesses to deliver profitable operating results in increasingly uncertain macroeconomic cond
NEW YORK, Jan. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024 compared with net income of $11.1 million or $1.07 basic earnings per share for the fourth quarter of 2023. Fourth quarter and full year 2024 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $20.5 million and $32.6 million, respectively, attributable to an increase in OPY Class A share price. Revenue for the fourth quarter of 2024 was $375.4 million compared to revenue of $308.3 million for the fourth quarter of 2023, an in
SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)
SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)
Mark Trafford Promoted to Serve Alongside Wright to Lead the Region NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced the appointment of David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest. Meanwhile, Mark Trafford has been promoted to serve alongside Wright to co-lead the region. Both report to Ed Harrington, Executive Vice President and Head of Private Client Division at Oppenheimer. "We are thrilled to welcome David to Oppenheimer," said Harrington. "He brings the right energy, deep market knowledge and leaders
Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK, July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph., Head of Oppenheimer's Healthcare Investment Banking Group, and work out of the firm's Miami and Atlanta offices. "On behalf of the entire Healthcare Investment Banking group, I'm pleased to welcome Jon to Oppenheimer," said Margolis. "Jon is a highly respected advi
NEW YORK, March 25, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in its Technology Investment Banking Group. He will be based in Oppenheimer's New York office and report to Robin Graham, Head of Technology Investment Banking. "Ranjot's M&A expertise with large and highly technical transactions across the Technology sector is the perfect addition to our growing advisory practice," Graham said. "He has advised both public and private companies at the highest levels and will complement the deep industry expertise of our most